Literature DB >> 2226549

Protein C activity and antigen levels in childhood.

A van Teunenbroek1, M Peters, A Sturk, J J Borm, C Breederveld.   

Abstract

Hereditary protein C deficiency is an important risk factor for thrombosis. To enable its diagnosis shortly after birth, we determined reference values of protein C antigen and activity levels for the first 3 months of life. To establish an age-related range of protein C levels we also determined median values for individuals up to 18 years of age. A good correlation between the two levels was seen from the 3rd/4th month of life onwards, whereas in the first 2 months the activity levels were significantly lower than the antigen levels. This was not due to interference by the increased plasma citrate concentration at high haematocrit values, and may suggest a dysfunctional protein C molecule in the neonatal period. We found a rapid rise in protein C activity and antigen levels until the age of 7-9 months, followed by a slower progression toward adolescence. In contrast to previous reports, our results indicate that adult values are probably not achieved until sometime during the 2nd decade of life.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226549     DOI: 10.1007/bf01957278

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

Review 1.  Coagulation problems in the newborn infant.

Authors:  W E Hathaway
Journal:  Pediatr Clin North Am       Date:  1970-11       Impact factor: 3.278

2.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

3.  Deficiencies of protein C, an inhibitor of blood coagulation.

Authors:  P M Mannucci; S Vigano
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

4.  Analytical and clinical evaluation of commercial protein C assays.

Authors:  A Sturk; W M Morrien-Salomons; M V Huisman; J J Borm; H R Büller; J W ten Cate
Journal:  Clin Chim Acta       Date:  1987-06-15       Impact factor: 3.786

5.  Development of the human coagulation system in the full-term infant.

Authors:  M Andrew; B Paes; R Milner; M Johnston; L Mitchell; D M Tollefsen; P Powers
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

6.  Proteolytic activation of protein C from bovine plasma.

Authors:  W Kisiel; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

7.  Activated protein C inhibits platelet prothrombin-converting activity.

Authors:  P C Comp; C T Esmon
Journal:  Blood       Date:  1979-12       Impact factor: 22.113

8.  Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.

Authors:  V W van Hinsbergh; R M Bertina; A van Wijngaarden; N H van Tilburg; J J Emeis; F Haverkate
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

9.  Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation.

Authors:  J H Griffin; D F Mosher; T S Zimmerman; A J Kleiss
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

10.  Deficiency of protein C in congenital thrombotic disease.

Authors:  J H Griffin; B Evatt; T S Zimmerman; A J Kleiss; C Wideman
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more
  3 in total

1.  Abnormalities in liver function and coagulation profile following the Fontan procedure.

Authors:  R C van Nieuwenhuizen; M Peters; L J Lubbers; M D Trip; J G Tijssen; B J Mulder
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

2.  Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia.

Authors:  Alexander Binder; Georg Endler; Sandra Rieger; Gotho Geishofer; Bernhard Resch; Christine Mannhalter; Werner Zenz
Journal:  Hum Genet       Date:  2007-06-14       Impact factor: 4.132

Review 3.  Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test.

Authors:  C Heleen van Ommen; Ulrike Nowak-Göttl
Journal:  Front Pediatr       Date:  2017-03-14       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.